Does lactoferrin improve survival free from morbidity in very low birth weightinfants? Lactoferrin Infant Feeding Trial: a randomised controlled trial
Phase 3
Active, not recruiting
- Conditions
- Premature babiessepsisInfection - Other infectious diseasesReproductive Health and Childbirth - Complications of newborn
- Registration Number
- ACTRN12611000247976
- Lead Sponsor
- niversity of Sydney
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 1542
Inclusion Criteria
Babies are eligible if (a) <1500 g birth weight (b) less than or equal to 7 days old and expected to survive and (c) parent gives written informed consent.
Exclusion Criteria
Babies with severe congenital anomalies which are likely to cause death are not eligible
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival to hospital discharge free from (i) 3 morbidities diagnosed or treated in hospital by 36<br>weeks corrected gestational age: brain injury or late onset sepsis or necrotising enterocolitis<br>(NEC); and, free from (ii) retinopathy treated according to local guidelines up to discharge from hospital.[before hospital Discharge]
- Secondary Outcome Measures
Name Time Method